Artemisinin alleviates obesity-related glomerulopathy by downregulating CYP24A1 expression

Diabetes Obes Metab. 2024 Feb;26(2):767-771. doi: 10.1111/dom.15355. Epub 2023 Nov 3.

Xiaorong Chen^{1

2}, Jie Xiang^{1

2}, Peng Gao³, Lijuan Wang³, Li Xiang⁴, Zongshi Lu³, Tingbing Cao³, Aidi Mou³, Xingping Zhang², Xiaoyan Jiang⁵, Zhiming Zhu³, Hongmei Lang²

¹ Medical College, Southwest Jiaotong University, Chengdu, China.
² Department of General Medicine, Chengdu Second People's Hospital, Chengdu, China.
³ Department of Hypertension and Endocrinology, Centre for Hypertension and Metabolic Diseases, Daping Hospital, Army Medical University, and Chongqing Institute of Hypertension, Chongqing, China.
⁴ Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
⁵ Department of Endocrinology and Metabolism, Chongqing Emergency Medical Centre, Chongqing University Central Hospital, Chongqing, China.

No abstract available

Keywords: CYP24A1; artemisinin; inflammation; obesity-related glomerulopathy; podocyte injury; vitamin D.

Publication types